These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32724389)

  • 1. Role of ubiquitin-conjugating enzyme E2T in the carcinogenesis and progression of pancreatic cancer.
    Zheng YW; Gao PF; Ma MZ; Chen Y; Li CY
    Oncol Lett; 2020 Aug; 20(2):1462-1468. PubMed ID: 32724389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin-conjugating enzyme E2T regulates cell proliferation and migration in cholangiocarcinoma.
    Liu F; Zhu C; Gao P; Zheng S; Li C
    Anticancer Drugs; 2020 Sep; 31(8):836-846. PubMed ID: 32796405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of ubiquitin-conjugating enzyme E2T in colorectal cancers and clinical implications.
    Wu X; Liu G; Liu R; He J; Wang G; Zhang H; Liu T; Bai J; Cheng N; Qiu J
    Oncol Lett; 2020 Nov; 20(5):275. PubMed ID: 33014154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin-conjugating enzyme E2T promotes tumor stem cell characteristics and migration of cervical cancer cells by regulating the GRP78/FAK pathway.
    Liu Y; Ji W; Yue N; Zhou W
    Open Life Sci; 2021; 16(1):1082-1090. PubMed ID: 34703898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin-Conjugating Enzyme E2T is an Independent Prognostic Factor and Promotes Gastric Cancer Progression.
    Yu H; Xiang P; Pan Q; Huang Y; Xie N; Zhu W
    Tumour Biol; 2016 Sep; 37(9):11723-11732. PubMed ID: 27020591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis
    Guo J; Wang M; Wang JP; Wu CX
    World J Gastroenterol; 2019 Nov; 25(43):6386-6403. PubMed ID: 31798276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-543 impairs breast cancer cell phenotypes by targeting and suppressing ubiquitin-conjugating enzyme E2T (UBE2T).
    Li L; Li Q
    Bioengineered; 2021 Dec; 12(2):12394-12406. PubMed ID: 34787051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UBE2T promotes glioblastoma invasion and migration via stabilizing GRP78 and regulating EMT.
    Huang P; Guo Y; Zhao Z; Ning W; Wang H; Gu C; Zhang M; Qu Y; Zhang H; Song Y
    Aging (Albany NY); 2020 Jun; 12(11):10275-10289. PubMed ID: 32491994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin-conjugating enzyme E2T(UBE2T) promotes colorectal cancer progression by facilitating ubiquitination and degradation of p53.
    Wu M; Li X; Huang W; Chen Y; Wang B; Liu X
    Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101493. PubMed ID: 32736946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UBE2T regulates epithelial-mesenchymal transition through the PI3K-AKT pathway and plays a carcinogenic role in ovarian cancer.
    Cui P; Li H; Wang C; Liu Y; Zhang M; Yin Y; Sun Z; Wang Y; Chen X
    J Ovarian Res; 2022 Sep; 15(1):103. PubMed ID: 36088429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UBE2T silencing suppresses proliferation and induces cell cycle arrest and apoptosis in bladder cancer cells.
    Gong YQ; Peng D; Ning XH; Yang XY; Li XS; Zhou LQ; Guo YL
    Oncol Lett; 2016 Dec; 12(6):4485-4492. PubMed ID: 28101210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UBE2T regulates FANCI monoubiquitination to promote NSCLC progression by activating EMT.
    Zhang J; Wang J; Wu J; Huang J; Lin Z; Lin X
    Oncol Rep; 2022 Aug; 48(2):. PubMed ID: 35703356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma.
    Hao P; Kang B; Li Y; Hao W; Ma F
    Mol Med Rep; 2019 Aug; 20(2):1212-1220. PubMed ID: 31173226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated expression of UBE2T exhibits oncogenic properties in human prostate cancer.
    Wen M; Kwon Y; Wang Y; Mao JH; Wei G
    Oncotarget; 2015 Sep; 6(28):25226-39. PubMed ID: 26308072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells.
    Ueki T; Park JH; Nishidate T; Kijima K; Hirata K; Nakamura Y; Katagiri T
    Cancer Res; 2009 Nov; 69(22):8752-60. PubMed ID: 19887602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UBE2T is upregulated, predicts poor prognosis, and promotes cell proliferation and invasion by promoting epithelial-mesenchymal transition via inhibiting autophagy in an AKT/mTOR dependent manner in ovarian cancer.
    Huang W; Huang H; Xiao Y; Wang L; Zhang T; Fang X; Xia X
    Cell Cycle; 2022 Apr; 21(8):780-791. PubMed ID: 35130130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UBE2T silencing inhibited non-small cell lung cancer cell proliferation and invasion by suppressing the wnt/β-catenin signaling pathway.
    Liu J; Liu X
    Int J Clin Exp Pathol; 2017; 10(9):9482-9488. PubMed ID: 31966822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UBE2T promotes proliferation via G2/M checkpoint in hepatocellular carcinoma.
    Liu LL; Zhu JM; Yu XN; Zhu HR; Shi X; Bilegsaikhan E; Guo HY; Wu J; Shen XZ
    Cancer Manag Res; 2019; 11():8359-8370. PubMed ID: 31571992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UBE2T promotes hepatocellular carcinoma cell growth via ubiquitination of p53.
    Liu LP; Yang M; Peng QZ; Li MY; Zhang YS; Guo YH; Chen Y; Bao SY
    Biochem Biophys Res Commun; 2017 Nov; 493(1):20-27. PubMed ID: 28935368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
    Hu W; Xiao L; Cao C; Hua S; Wu D
    Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.